NeOnc Technologies Holdings, Inc. (NTHI)Healthcare | Biotechnology | Calabasas, United States | NasdaqGM
5.34 USD
+0.32
(6.422%)
⇧
(April 17, 2026, 3:55 p.m.
EDT)
Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 4:27 p.m. EDT
NTHI is a highly volatile stock with a significant negative forward PE and trailing EPS, indicating poor profitability. The recent price movement shows a decline from a high of $12.99 to a current price of $5.44, with a 52-week low of $3.20, suggesting a bearish trend. The stock has a low volume and a high short ratio, indicating potential short-term volatility. The recent news highlights some positive developments, such as strategic partnerships and insider buying, but these are offset by the company's financial struggles, including negative book value and operating margins. Given the lack of dividend history and the poor fundamentals, it is not advisable to invest in this stock for either short-term or long-term. The forecasting model shows minimal predicted price change, but the high H-Stat and low p-values indicate potential instability in the model's predictions. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.183563 |
| AutoETS | 0.183580 |
| AutoARIMA | 0.183580 |
| MSTL | 0.187049 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 27.29 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.049 |
| Excess Kurtosis | -0.76 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.002 |
| Market Cap | 133,087,104 |
| Forward P/E | -3.61 |
| Website | https://www.neonc.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.20569623 |
| Address1 | 23,975 Park Sorrento |
| Address2 | Suite 205 |
| All Time High | 25.0 |
| All Time Low | 3.2 |
| Ask | 5.49 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 60,310 |
| Average Daily Volume3 Month | 50,654 |
| Average Volume | 50,654 |
| Average Volume10Days | 60,310 |
| Bid | 5.1 |
| Bid Size | 1 |
| Book Value | -0.807 |
| City | Calabasas |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 5.3424 |
| Current Ratio | 0.069 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 5.572 |
| Day Low | 4.96 |
| Display Name | NeOnc |
| Earnings Timestamp | 1,774,960,200 |
| Earnings Timestamp End | 1,778,848,200 |
| Earnings Timestamp Start | 1,778,848,200 |
| Ebitda Margins | 0.0 |
| Enterprise To Revenue | 3,144.845 |
| Enterprise Value | 125,762,352 |
| Eps Current Year | -1.48 |
| Eps Forward | -1.48 |
| Eps Trailing Twelve Months | -3.2 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 8.283 |
| Fifty Day Average Change | -2.9406 |
| Fifty Day Average Change Percent | -0.3550163 |
| Fifty Two Week Change Percent | -20.569622 |
| Fifty Two Week High | 12.99 |
| Fifty Two Week High Change | -7.6475997 |
| Fifty Two Week High Change Percent | -0.5887298 |
| Fifty Two Week Low | 3.2 |
| Fifty Two Week Low Change | 2.1424 |
| Fifty Two Week Low Change Percent | 0.6695 |
| Fifty Two Week Range | 3.2 - 12.99 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,742,995,800,000 |
| Float Shares | 8,151,963 |
| Forward Eps | -1.48 |
| Forward P E | -3.6097298 |
| Free Cashflow | 5,714,717 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 5 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 1.0 |
| Gross Profits | 39,990 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.5844 |
| Held Percent Institutions | 0.08552 |
| Implied Shares Outstanding | 24,911,482 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,025-03-26 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California. |
| Long Name | NeOnc Technologies Holdings, Inc. |
| Market | us_market |
| Market Cap | 133,087,104 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_1847121177 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -62,146,208 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 125,055,639 |
| Open | 4.96 |
| Operating Cashflow | -20,363,948 |
| Operating Margins | -1,456.3751 |
| Payout Ratio | 0.0 |
| Phone | 310 663 7831 |
| Previous Close | 5.02 |
| Price Eps Current Year | -3.6097298 |
| Price Hint | 2 |
| Price To Book | -6.6200747 |
| Price To Sales Trailing12 Months | 3,328.0095 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.01 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.3224001 |
| Regular Market Change Percent | 6.4223127 |
| Regular Market Day High | 5.572 |
| Regular Market Day Low | 4.96 |
| Regular Market Day Range | 4.96 - 5.572 |
| Regular Market Open | 4.96 |
| Regular Market Previous Close | 5.02 |
| Regular Market Price | 5.3424 |
| Regular Market Time | 1,776,455,730 |
| Regular Market Volume | 21,052 |
| Return On Assets | -11.665119 |
| Revenue Growth | -1.0 |
| Revenue Per Share | 0.002 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 24,608,716 |
| Shares Percent Shares Out | 0.012200001 |
| Shares Short | 289,781 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 214,975 |
| Short Name | NeOnc Technologies Holdings, In |
| Short Percent Of Float | 0.0209 |
| Short Ratio | 7.89 |
| Source Interval | 15 |
| State | CA |
| Symbol | NTHI |
| Total Cash | 58,729 |
| Total Cash Per Share | 0.002 |
| Total Debt | 6,313,879 |
| Total Revenue | 39,990 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.2 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 8.21844 |
| Two Hundred Day Average Change | -2.87604 |
| Two Hundred Day Average Change Percent | -0.34994963 |
| Type Disp | Equity |
| Volume | 21,052 |
| Website | https://www.neonc.com |
| Zip | 91,302 |